Lyu, Su Ir ORCID: 0009-0002-4125-6048, Fretter, Caroline, Hillmer, Axel M. ORCID: 0000-0002-3381-7266, Grothey, Bastian ORCID: 0000-0002-0883-6481, Hoppe, Sascha ORCID: 0000-0001-9246-3747, Simon, Adrian Georg ORCID: 0000-0002-2709-863X, Zander, Thomas ORCID: 0000-0002-4266-6818, Knipper, Karl ORCID: 0009-0008-7133-3538, Schroeder, Wolfgang ORCID: 0000-0002-8700-069X, Bruns, Christiane J. ORCID: 0000-0001-6590-8181 and Quaas, Alexander ORCID: 0000-0002-3537-6011 (2025). Basal-like subtype of esophageal adenocarcinoma and it’s morphological, molecular and clinical characteristics. Scientific Reports, 15 (1). pp. 1-12. Springer Nature. ISSN 2045-2322

[thumbnail of s41598-025-08721-9.pdf] PDF
s41598-025-08721-9.pdf
Bereitstellung unter der CC-Lizenz: Creative Commons Attribution.

Download (2MB)
Identification Number:10.1038/s41598-025-08721-9

Abstract

[Artikel-Nr.: 24680] Esophageal adenocarcinoma (EAC) and squamous cell carcinoma are the two main tumor types of the esophagus, each with distinct morphological and molecular features. While mixed adeno-squamous carcinomas are recognized, it remains unclear whether a basal-like subtype—known from breast and pancreatic adenocarcinomas—also exists in EAC. This study analyzed tumor samples from 953 patients with operable EAC for expression of the basal cytokeratins CK5 and CK6. Tumors with any squamous differentiation were excluded. A small subset (3.4%) showed a basal-like phenotype, characterized by high CK5 and/or CK6 expression and small-luminal tubular growth. High CK5 expression was associated with significantly worse overall survival, and within the neoadjuvantly treated subgroup, it emerged as an independent negative prognostic marker. Tumors with concurrent high CK5 and CK6 expression also showed reduced survival. Exploratory analyses revealed potential associations between CK6 expression and Claudin18.2 status, and between CK5 expression and Y-chromosome loss. These findings indicate the presence of a distinct basal-like subtype within EAC, linked to poor prognosis and possible molecular differences. CK5, alone or in combination with CK6, may serve as a practical biomarker for identifying this subtype and could support the development of more personalized treatment strategies.

Item Type: Article
Creators:
Creators
Email
ORCID
ORCID Put Code
Lyu, Su Ir
UNSPECIFIED
UNSPECIFIED
Fretter, Caroline
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Hillmer, Axel M.
UNSPECIFIED
UNSPECIFIED
Grothey, Bastian
UNSPECIFIED
UNSPECIFIED
Hoppe, Sascha
UNSPECIFIED
UNSPECIFIED
Simon, Adrian Georg
UNSPECIFIED
UNSPECIFIED
Zander, Thomas
UNSPECIFIED
UNSPECIFIED
Knipper, Karl
UNSPECIFIED
UNSPECIFIED
Schroeder, Wolfgang
UNSPECIFIED
UNSPECIFIED
Bruns, Christiane J.
UNSPECIFIED
UNSPECIFIED
Quaas, Alexander
UNSPECIFIED
UNSPECIFIED
URN: urn:nbn:de:hbz:38-809564
Identification Number: 10.1038/s41598-025-08721-9
Journal or Publication Title: Scientific Reports
Volume: 15
Number: 1
Page Range: pp. 1-12
Number of Pages: 12
Date: 9 July 2025
Publisher: Springer Nature
ISSN: 2045-2322
Language: English
Faculty: Faculty of Medicine
Divisions: Faculty of Medicine > Chirurgie > Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Transplantationschirurgie
Faculty of Medicine > Innere Medizin > Klinik II für Innere Medizin - Nephrologie, Rheumatologie, Diabetologie und Allgemeine Innere Medizin
Faculty of Medicine > Pathologie und Neuropathologie > Institut für Pathologie
Subjects: Medical sciences Medicine
Uncontrolled Keywords:
Keywords
Language
Esophageal adenocarcinoma ; Cytokeratin 5 ; Cytokeratin 6 ; Basal-like subtype ; Poor prognosis
English
['eprint_fieldname_oa_funders' not defined]: Publikationsfonds UzK
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/80956

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item